UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 174 filers reported holding UNIQURE NV in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,280,758 | -42.6% | 3,171,499 | -2.0% | 1.82% | -49.3% |
| Q2 2023 | $37,092,399 | -46.7% | 3,236,684 | -6.4% | 3.59% | -32.8% |
| Q1 2023 | $69,645,349 | -21.0% | 3,458,061 | -11.1% | 5.34% | -6.6% |
| Q4 2022 | $88,139,577 | +20.4% | 3,887,939 | -0.4% | 5.71% | +20.6% |
| Q3 2022 | $73,200,000 | +0.9% | 3,901,929 | +0.3% | 4.74% | +30.2% |
| Q2 2022 | $72,524,000 | +8.4% | 3,890,757 | +5.1% | 3.64% | +22.9% |
| Q1 2022 | $66,885,000 | -27.8% | 3,701,459 | -17.2% | 2.96% | -9.2% |
| Q4 2021 | $92,691,000 | -25.1% | 4,469,213 | +15.6% | 3.26% | -16.4% |
| Q3 2021 | $123,723,000 | +3.8% | 3,865,118 | -0.1% | 3.90% | +15.2% |
| Q2 2021 | $119,155,000 | +11.5% | 3,868,666 | +21.9% | 3.39% | +8.4% |
| Q1 2021 | $106,895,000 | +7.6% | 3,172,891 | +15.4% | 3.12% | +1.5% |
| Q4 2020 | $99,324,000 | +1.9% | 2,749,039 | +3.9% | 3.08% | +3.2% |
| Q3 2020 | $97,447,000 | -17.8% | 2,645,858 | +0.6% | 2.98% | -16.6% |
| Q2 2020 | $118,537,000 | -4.7% | 2,630,649 | +0.3% | 3.58% | -23.3% |
| Q1 2020 | $124,403,000 | -30.2% | 2,621,772 | +5.4% | 4.66% | -15.1% |
| Q4 2019 | $178,208,000 | +15.1% | 2,486,838 | -36.8% | 5.49% | -4.3% |
| Q3 2019 | $154,835,000 | -34.4% | 3,933,838 | +30.3% | 5.74% | -21.0% |
| Q2 2019 | $235,932,000 | +45.5% | 3,018,960 | +11.0% | 7.27% | +43.6% |
| Q1 2019 | $162,170,000 | +57.2% | 2,718,690 | -24.0% | 5.06% | +59.4% |
| Q4 2018 | $103,137,000 | -23.0% | 3,578,667 | -2.8% | 3.17% | -12.0% |
| Q3 2018 | $134,005,000 | -0.3% | 3,682,471 | +3.5% | 3.60% | -33.8% |
| Q2 2018 | $134,433,000 | +144.5% | 3,556,439 | +52.0% | 5.44% | +119.6% |
| Q1 2018 | $54,985,000 | +17.9% | 2,339,774 | -1.7% | 2.48% | +19.6% |
| Q4 2017 | $46,642,000 | +333.8% | 2,380,890 | +112.6% | 2.07% | +293.4% |
| Q3 2017 | $10,751,000 | +56.8% | 1,119,883 | +1.1% | 0.53% | -3.1% |
| Q2 2017 | $6,855,000 | +196.5% | 1,107,483 | +176.9% | 0.54% | +110.9% |
| Q1 2017 | $2,312,000 | +3.2% | 400,000 | 0.0% | 0.26% | +10.7% |
| Q4 2016 | $2,240,000 | – | 400,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |